搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 1 小时
时间不限
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
37 分钟
Losing Weight With Ozempic Might Also Lighten Your Bar Tab, Study Finds
A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be ...
21 分钟
TennCare requesting $118M for popular weight loss, Type 2 diabetes drugs
TennCare is federally required to cover GLP-1 drugs; of the $118M in the cost increase request, more than $76 million would ...
31 分钟
Medicare coverage of weight-loss drugs would drive up costs by billions of dollars
President Joe Biden’s proposal to have GLP-1 weight-loss drugs such as Ozempic and Mounjaro covered by Medicare and Medicaid ...
14 分钟
Doctors Share The Best Thanksgiving Foods If You’re On Ozempic
Doctors share the best and worst Thanksgiving foods if you're taking a GLP-1s like Ozempic. Some dishes might make you "bloated, nauseous, and uncomfortable.” ...
30 分钟
Biden wants Medicare, Medicaid to cover weight-loss drugs
Proposal would let patients get Wegovy, Ozempic, related drugs for obesity, which is not a covered condition now.
腾讯网
44 分钟
安进减肥药减重20%的效果亮眼,但副作用较高,股价一度大跌12.3%!
周二,由于拜登政府计划将减肥药纳入医保和补助计划,诺和诺德一度涨超3%,礼来一度涨近6.9%。在减肥药企普涨之际,安进公司(AMGN)却一度大跌超12.3%,原因是虽然安进的MariTide减肥药的疗效符合华尔街预期,但由于副作用较高且未能击败礼来公 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈